An overview of sipuleucel-T: Autologous cellular immunotherapy for prostate cancer

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer Immunotherapy

(2011) Robert O. Dillman   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Clinical development directions in oncolytic viral therapy

(2011) R M Eager et al.   CANCER GENE THERAPY

Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research

(2011) J. L. Gulley et al.   CLINICAL CANCER RESEARCH

Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer

(2011) T. M. Beer et al.   CLINICAL CANCER RESEARCH

Immunotherapies in Clinical Trials: Do They Demand Different Evaluation Tools?

(2011) R. S. Tuma   JNCI-Journal of the National Cancer Institute

Integrated Safety Data From 4 Randomized, Double-Blind, Controlled Trials of Autologous Cellular Immunotherapy With Sipuleucel-T in Patients With Prostate Cancer

(2011) Simon J. Hall et al.   JOURNAL OF UROLOGY

646 SAFETY OF LEUKAPHERESIS IN PROSTATE CANCER PATIENTS RECEIVING SIPULEUCEL-T

(2011) Robert Flanigan et al.   JOURNAL OF UROLOGY

Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer

(2011) Robert B. Sims   VACCINE

Cellular Vaccine Approaches

(2010) Dung T. Le et al.   CANCER JOURNAL

Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy

(2010) W. D. Stein et al.   CLINICAL CANCER RESEARCH

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force

(2010) Lisa H Butterfield et al.   Journal of Translational Medicine

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression

(2010) R. A. Madan et al.   ONCOLOGIST

Therapeutic antibodies: successes, limitations and hopes for the future

(2009) Patrick Chames et al.   BRITISH JOURNAL OF PHARMACOLOGY

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

(2009) Celestia S. Higano et al.   CANCER

Adoptive transfer of virus-specific and tumor-specific T cell immunity

(2009) Carolina Berger et al.   CURRENT OPINION IN IMMUNOLOGY

T Cell Receptor Gene Therapy for Cancer

(2009) Thomas M. Schmitt et al.   HUMAN GENE THERAPY

CD54 is a surrogate marker of antigen presenting cell activation

(2008) N. A. Sheikh et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials

(2008) Severine Loisel-Meyer   Frontiers in Bioscience-Landmark

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

(2008) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY

The Immune System — is it Relevant to Cancer Development, Progression and Treatment?

(2007) R.J. Prestwich et al.   CLINICAL ONCOLOGY

Plasmid DNA- and messenger RNA-based anti-cancer vaccination

(2007) Benjamin Weide et al.   IMMUNOLOGY LETTERS